skip navigation
A B C D E F G H I J K L M N O P Q

Test Identifier Information

 
Registration CodePGSA
Method

PGS analysis involves screening embryos produced during in vitro fertilisation (IVF) to identify embryos that have the correct number of chromosomes (euploidy); embryos with an incorrect number of chromosomes (anneuploid) are not considered for transfer.

To analyse day-5 (trophectoderm) biopsies from human embryos, CHL uses a whole genome amplification (WGA) step, followed by array-CGH microarray (Agilent Genetisure).

Diagnostic Use / Indications

PGS may be recommended for women of advanced maternal age who are known to be at higher risk of producing anneuploid embryos. It is also an option for couples who have had multiple miscarriages.

PGS is not funded publicly. Since PGS is part of IVF treatment, access to PGS testing is through a fertility clinic who will arrange testing directly with CHL.

External Price$0.00(Exclusive of GST)
  

Specimen Collection

 
Patient SpecimenBiopsied cells from human embryos.
  

CHLabs Laboratory

 
DepartmentBiochemistry - Molecular Pathology
Contact Details Email Email
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Contact Phone Number03 364 0548

CHL Follow us on Facebook